Cronos Group Inc. (CRON) vs Nektar Therapeutics (NKTR)
A side-by-side comparison of Cronos Group Inc. and Nektar Therapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRON
Cronos Group Inc.
$3.26HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
NKTR
Nektar Therapeutics
$41.14HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — CRON vs NKTR
growth of $100 · dividends reinvested · last 10yCRON +258.4% (+13.6%/yr)NKTR -83.4% (-16.4%/yr)CRON compounded faster over this window
Log scale — wide-divergence pair
CRON NKTR
CRON vs NKTR: by the numbers
- •CRON is the larger company ($1.22B vs $1.18B market cap).
- •CRON is profitable (30.98% net margin) while NKTR runs a net loss (-287.84%).
- •CRON grew revenue faster over the past five years (31.80% vs -12.34% CAGR).
Metrics side by side
Valuation
| Metric | CRON | NKTR |
|---|---|---|
| P/E ratio | 17.97 | N/A |
| P/S ratio | 5.40 | 21.62 |
| P/B ratio | 1.14 | 1.31 |
| EV / EBITDA | 27.67 | N/A |
| FCF yield | 4.09% | N/A |
Profitability
| Metric | CRON | NKTR |
|---|---|---|
| Gross margin | 36.16% | 99.36% |
| Operating margin | -11.96% | -240.38% |
| Net margin | 30.98% | -287.84% |
| ROE | 6.53% | -17.40% |
| ROIC | 1.12% | -12.53% |
Growth (annualized)
| Metric | CRON | NKTR |
|---|---|---|
| Revenue CAGR (5Y) | 31.80% | -12.34% |
| Total return CAGR (5Y) | -9.92% | -30.33% |
Frequently asked
- Which has grown faster, CRON or NKTR?
- Over the past five years, CRON grew revenue faster — CRON at a 31.80% CAGR versus NKTR at -12.34%.
- Is CRON or NKTR more profitable?
- CRON runs the higher net margin — CRON at 30.98% versus NKTR at -287.84%.
- How have CRON and NKTR total returns compared?
- Over the past 10 years, CRON delivered 13.62% and NKTR delivered -16.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cronos P/E ratioCronos ROENektar Therapeutics ROECronos operating marginNektar Therapeutics operating marginCronos revenue growthNektar Therapeutics revenue growthCronos free cash flowNektar Therapeutics free cash flow
Cronos & Nektar Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.